SMILES,Conditions,Name,NCT_Number,Phases,Status,Gender,Age,Funded Bys,Study Designs,Locations,Patent_id,CPC,Gender_code_0,Gender_code_1,Gender_code_2,Gender_code_3,Age_code_0,Age_code_1,Age_code_2,Age_code_3,Age_code_4,Age_code_5,Allocation_Type_0,Allocation_Type_1,Allocation_Type_2,Allocation_Type_3,Intervention_Model_0,Intervention_Model_1,Intervention_Model_2,Intervention_Model_3,Intervention_Model_4,Intervention_Model_5,Country_0,Country_1,Country_2,Country_3,Country_4,Country_5,Funder_Type_0,Funder_Type_1,Funder_Type_2,Funder_Type_3,Funder_Type_4,Funder_Type_5,claims_#,Duration,Patent_#,PCT_code_0,PCT_code_1,CPC_code_0,CPC_code_2,CPC_code_3,CPC_code_4,CPC_code_5,PCT_code_2,CPC_code_1,logP,MW,PSA,HBA,HBD,Rings,Polarizability,Refractivity,Bond_#,Bioavailability_0,Bioavailability_1,Bioavailability_2,ECFP4.1,ECFP4.2,ECFP4.3,ECFP4.4,ECFP4.5,ECFP4.6,ECFP4.7,ECFP4.8,ECFP4.9,ECFP4.10,ECFP4.11,ECFP4.12,ECFP4.13,ECFP4.14,ECFP4.15,ECFP4.16,ECFP4.17,ECFP4.18,ECFP4.19,ECFP4.20,ECFP4.21,ECFP4.22,ECFP4.23,ECFP4.24,ECFP4.25,ECFP4.26,ECFP4.27,ECFP4.28,ECFP4.29,ECFP4.30,ECFP4.31,ECFP4.32,ECFP4.33,ECFP4.34,ECFP4.35,ECFP4.36,ECFP4.37,ECFP4.38,ECFP4.39,ECFP4.40,ECFP4.41,ECFP4.42,ECFP4.43,ECFP4.44,ECFP4.45,ECFP4.46,ECFP4.47,ECFP4.48,ECFP4.49,ECFP4.50,ECFP4.51,ECFP4.52,ECFP4.53,ECFP4.54,ECFP4.55,ECFP4.56,ECFP4.57,ECFP4.58,ECFP4.59,ECFP4.60,ECFP4.61,ECFP4.62,ECFP4.63,ECFP4.64,ECFP4.65,ECFP4.66,ECFP4.67,ECFP4.68,ECFP4.69,ECFP4.70,ECFP4.71,ECFP4.72,ECFP4.73,ECFP4.74,ECFP4.75,ECFP4.76,ECFP4.77,ECFP4.78,ECFP4.79,ECFP4.80,ECFP4.81,ECFP4.82,ECFP4.83,ECFP4.84,ECFP4.85,ECFP4.86,ECFP4.87,ECFP4.88,ECFP4.89,ECFP4.90,ECFP4.91,ECFP4.92,ECFP4.93,ECFP4.94,ECFP4.95,ECFP4.96,ECFP4.97,ECFP4.98,ECFP4.99,ECFP4.100,ECFP4.101,ECFP4.102,ECFP4.103,ECFP4.104,ECFP4.105,ECFP4.106,ECFP4.107,ECFP4.108,ECFP4.109,ECFP4.110,ECFP4.111,ECFP4.112,ECFP4.113,ECFP4.114,ECFP4.115,ECFP4.116,ECFP4.117,ECFP4.118,ECFP4.119,ECFP4.120,ECFP4.121,ECFP4.122,ECFP4.123,ECFP4.124,ECFP4.125,ECFP4.126,ECFP4.127,ECFP4.128
CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,OSTEOARTHRITIS,_VANCOMYCIN,NCT04075526,Not Applicable,Recruiting,All,"18 Years to 100 Years   (Adult, Older Adult)",Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"Eisenhower Health, Rancho Mirage, California, United States|Cleveland Clinic Florida, Weston, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|New England Baptist Hospital, Boston, Massachusetts, United States|New York University Dept of Orthopeadic Surgery, New York, New York, United States|Hospital for Special Surgery, New York, New York, United States|Mount Sinai Hospital, New York, New York, United States|Columbia, New York, New York, United States|Cleveland Clinic Ohio, Cleveland, Ohio, United States|Inova Mount Vernon Hospital, Alexandria, Virginia, United States",10188697,A61K9/08,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,26.0,38.768763218957204,1648.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.11,1449.254,530.49,24.0,19.0,10.0,138.7,346.61,13.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,OSTEOPENIA,_MELATONIN,NCT04233112,Early Phase 1,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","OsteoStrong® in Scott Towne Center, Pittsburgh, Pennsylvania, United States|Duquesne University, Pittsburgh, Pennsylvania, United States",4309415,5,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,37.0,32.854884083862,1835.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.42,232.2783,54.12,2.0,2.0,2.0,25.65,66.28,4.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0
O=C([O-])[O-].[Ca+2],LIVER CIRRHOSIS,_CALCIUM_CARBONATE,NCT02642874,Phase 3,Recruiting,All,18 Years to 60 Years   (Adult),Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"Tanta university - faculty of medicine, Tanta, Elgharbia, Egypt",5989588,A61K33/10,1.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,25.0,25.7582291217478,7.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.47,100.087,63.19,3.0,0.0,0.0,3.52,31.17,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0
COc1ccccc1OCC(O)COC(N)=O,LIVER CIRRHOSIS,_METHOCARBAMOL,NCT02642874,Phase 3,Recruiting,All,18 Years to 60 Years   (Adult),Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"Tanta university - faculty of medicine, Tanta, Elgharbia, Egypt",3968147.0,C07C29/145,1.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,21.0,20.238608595659002,207.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.63,241.2405,91.01,4.0,2.0,1.0,24.28,59.07,7.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0
O=C([O-])[O-].[Ca+2],OSTEOPOROSIS,_CALCIUM_CARBONATE,NCT04550078,Not Applicable,Recruiting,Female,"50 Years to 65 Years   (Adult, Older Adult)",Other|Industry,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","Zealand University Hospital, Køge, Denmark",5989588,A61K33/10,0.0,1.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,0.0,0.0,1.0,0.0,0.0,25.0,25.7582291217478,7.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.47,100.087,63.19,3.0,0.0,0.0,3.52,31.17,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0
CN(C)C(=N)NC(=N)N,RHEUMATOID ARTHRITIS,_METFORMIN,NCT04068246,Early Phase 1,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","Faculty of Pharmacy, Sadat City, Egypt",6288095.0,4,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,10.0,80.757305078133,88.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,-1.8,129.1636,88.99,5.0,4.0,0.0,13.43,56.64,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C,RHEUMATOID ARTHRITIS,_ANGIOTENSIN,NCT03770702,Phase 3,Recruiting,All,"18 Years to 65 Years   (Adult, Older Adult)",Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"Sherief Abd-Elsalam, Tanta, Egypt",,,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,15.0,32.7488,128.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,2.1233,442.0703,112.1969,5.0,2.0,3.0,44.7137,115.5493,5.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,RHEUMATOID ARTHRITIS,_MONTELUKAST,NCT03770923,Phase 3,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"Sherief Abd-Elsalam, Tanta, Egypt",8007830.0,A61K9/1623,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,5.0,42.711349309020704,165.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,7.25,586.183,70.42,4.0,2.0,5.0,66.36,169.5,12.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0
Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1,RHEUMATOID ARTHRITIS,_RUPATADINE,NCT03770923,Phase 3,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"Sherief Abd-Elsalam, Tanta, Egypt",5407941,C07D401/04,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,6.0,23.0312737427873,128.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,4.82,415.97,29.02,3.0,0.0,5.0,46.98,133.83,2.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
NCC(CC(=O)O)c1ccc(Cl)cc1,CIRRHOSIS,_BACLOFEN,NCT04509336,Not Applicable,Recruiting,All,"18 Years to 70 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","Tanta University Hospitals, Tanta, Egypt",6024981.0,A61K9/0056,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,40.0,22.242756524774602,351.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,-0.82,213.66099999999997,63.32,3.0,2.0,1.0,21.13,54.83,4.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0
Cc1ccccc1C(OCCN(C)C)c1ccccc1,CIRRHOSIS,_ORPHENADRINE,NCT04509336,Not Applicable,Recruiting,All,"18 Years to 70 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","Tanta University Hospitals, Tanta, Egypt",4551473,4,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,3.0,18.333025318795,299.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.5,269.3813,12.47,2.0,0.0,2.0,31.83,84.97,6.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0
COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,DIABETIC FOOT ULCER,_ESMOLOL,NCT03998436,Phase 3,Recruiting,All,"18 Years to 75 Years   (Adult, Older Adult)",Industry,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","M.S. Ramaiah Medical College and Hospital, Bangalore, Karnataka, India|Deenanath Mangeshkar Hospital and Research Center, Pune, Maharashtra, India|Chellaram Diabetes Institute, Pune, Maharashtra, India|M.V. Hospital for Diabetes Pvt Ltd, Chennai, Tamilnadu, India|Madras Diabetes Research Foundation, Chennai, Tamilnadu, India|Sri Ramachandra Hospital, Chennai, Tamilnadu, India|Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India|Maharaja Agrasen Hospital, New Delhi, India",6310094.0,2,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,9.0,9.56077126840386,564.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.02,295.374,67.79,4.0,2.0,1.0,33.68,81.05,10.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0
COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1.Cl,DIABETIC FOOT ULCER,_ESMOLOL_HYDROCHLORIDE,NCT03998436,Phase 3,Recruiting,All,"18 Years to 75 Years   (Adult, Older Adult)",Industry,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","M.S. Ramaiah Medical College and Hospital, Bangalore, Karnataka, India|Deenanath Mangeshkar Hospital and Research Center, Pune, Maharashtra, India|Chellaram Diabetes Institute, Pune, Maharashtra, India|M.V. Hospital for Diabetes Pvt Ltd, Chennai, Tamilnadu, India|Madras Diabetes Research Foundation, Chennai, Tamilnadu, India|Sri Ramachandra Hospital, Chennai, Tamilnadu, India|Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India|Maharaja Agrasen Hospital, New Delhi, India",6310094,2,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,9.0,9.56077126840386,155.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.1233,442.0703,112.1969,5.0,2.0,3.0,44.7137,115.5493,5.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0
O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,BREAST CANCER,_DICLOFENAC,NCT04511832,Not Applicable,Recruiting,All,"20 Years and older   (Adult, Older Adult)",Other,Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other,"China Medical University Hospital, Taichung, Taiwan",6407079,4,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,35.0,163.551612969465,1298.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,4.98,296.149,49.33,3.0,2.0,2.0,27.93,75.46,4.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,DIABETIC FOOT ULCER,_CHLORHEXIDINE,NCT03503370,Phase 2,Recruiting,All,"18 Years and older   (Adult, Older Adult)",U.S. Fed,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore, Maryland, United States",5538353,A45D34/04,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0,0.0,0.0,0.0,0.0,1.0,20.0,10.940676399926,1621.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.71,505.44699999999995,167.58,10.0,10.0,2.0,54.6,181.71,9.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,GOUT ATTACK,_BETAMETHASONE,NCT04306653,Not Applicable,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"University Hospital of Patras, PAtras, Achaia, Greece",6126920.0,5,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,15.0,32.6906096634427,1325.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.93,392.4611,94.83,5.0,3.0,4.0,40.81,102.49,2.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,PSORIATIC ARTHRITIS,_TOFACITINIB,NCT03486457,Phase 3,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Industry,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China|Anhui Provincial Hospital, Hefei, Anhui, China|The First Affiliated Hospital of Anhui Medical University/Rheumatology Department, Hefei, Anhui, China|Peking University First Hospital, Beijing, Beijing, China|Peking Union Medical College Hospital, Beijing, Beijing, China|The First Affiliated Hospital of Army Medical University, PLA, Chongqing, Chongqing, China|The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China|Guangzhou First People's Hospital, Guangzhou, Guangdong, China|Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China|The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China|The Third Hospital of Hebei Medical University, Rheumatology and Immunology Department, Shijiazhuang, Hebei, China|Rheumatology Department, The first Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China|Xiangya Hospital Central South University, Changsha, Hunan, China|The Second Xiangya Hospital of Central South University, Changsha, Hunan, China|Zhuzhou Central Hospital, Zhuzhou, Hunan, China|The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China|Department of Rheumatology, The First People's Hospital of Changzhou, Changzhou, Jiangsu, China|Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China|Jiangsu Province Hospital, Nanjing, Jiangsu, China|Affiliated Hospital of Nantong University, Nantong, Jiangsu, China|Department of Rheumatology ,The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China|Department of Rheumatology, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China|Jiu Jiang No.1 People's Hospital, Jiujiang, Jiangxi, China|Pingxiang People's Hospital, Pingxiang, Jiangxi, China|The First hospital of Jilin University, Changchun, Jilin, China|Linyi People's Hospital, Linyi, Shandong, China|Zhongshan Hospital Fudan University, Shanghai, Shanghai, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China|Department of Rheumatology and Immunology,West China Hospital，Sichuan University, Chengdu, Sichuan, China|Tianjin Medical University General Hospital, Rheumatology and Immunology Department, Tianjin, Tianjin, China|First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China|Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China|The First Affiliated Hosptial of Wenzhou Medical University, Wenzhou, Zhejiang, China|Peking Union Medical College Hospital, Beijing, China|Rheumatology and Immunology Department, Xuanwu Hospital Capital Medical University, Beijing, China|Huashan Hospital, Fudan University, Shanghai, China|Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China",7301023,C07D487/04,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,1.0,66.1697365448982,52.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.58,312.3696,88.91,5.0,1.0,3.0,32.65,87.8,3.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,RHEUMATOID ARTHRITIS,_INDOCYANINE_GREEN,NCT02680067,Phase 1,Recruiting,All,"18 Years to 89 Years   (Adult, Older Adult)",Other|NIH,Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science,"University of Rochester, Rochester, New York, United States",6915154,A61B5/0261,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0,0.0,0.0,0.0,1.0,0.0,11.0,58.7773876260292,7.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.26,753.99,114.99,7.0,2.0,6.0,87.2,231.13,14.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0
CCCCCC1=CC(=O)C=C(OC)C1=O,STROKE,_PRIMIN,NCT03517657,Not Applicable,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Northwestern University and Shirley Ryan Ability Lab, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States",7381433,A61K36/185,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,16.0,16.8217006509373,3.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.1233,442.0703,112.1969,5.0,2.0,3.0,44.7137,115.5493,5.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,SPONDYLOARTHRITIS,_UPADACITINIB,NCT04169373,Phase 3,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Industry,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Arizona Arthritis & Rheumatology Associates, P.C. /ID# 215282, Flagstaff, Arizona, United States|AZ Arthritis and Rheum Researc /ID# 215113, Phoenix, Arizona, United States|Arizona Arthritis & Rheumatology Research, PLLC /ID# 214731, Tucson, Arizona, United States|Newport Huntington Medical Group /ID# 216281, Huntington Beach, California, United States|Inland Rheum & Osteo Med Grp /ID# 215807, Upland, California, United States|Denver Arthritis Clinic /ID# 215346, Denver, Colorado, United States|Tekton Research /ID# 215054, Fort Collins, Colorado, United States|AARDS Research, Inc. /ID# 215306, Aventura, Florida, United States|Sweet Hope Research Specialty Inc /ID# 215931, Hialeah, Florida, United States|Innovation Medical Research Center /ID# 216068, Palmetto Bay, Florida, United States|Conquest Research /ID# 215804, Winter Park, Florida, United States|Great Lakes Clinical Trials /ID# 215790, Chicago, Illinois, United States|Greater Chicago Specialty Physicians /ID# 216213, Schaumburg, Illinois, United States|Clinical Investigation Specialists - Skokie /ID# 215055, Skokie, Illinois, United States|Klein & Associates, M.D., P.A. /ID# 214767, Cumberland, Maryland, United States|Tufts Medical Center /ID# 215925, Boston, Massachusetts, United States|Clinical Pharmacology Study Gr /ID# 215293, Worcester, Massachusetts, United States|Wayne State University Health Center /ID# 215930, Detroit, Michigan, United States|Advanced Rheumatology, PC /ID# 214973, Lansing, Michigan, United States|Saint Paul Rheumatology /ID# 215537, Eagan, Minnesota, United States|CenterPointe Institute of Research /ID# 215793, Saint Louis, Missouri, United States|Clinvest Research LLC /ID# 215785, Springfield, Missouri, United States|NYU Langone Orthopedic Center /ID# 215594, New York, New York, United States|St. Lawrence Health System /ID# 215844, Potsdam, New York, United States|Cape Fear Arthritis Care /ID# 215927, Leland, North Carolina, United States|Marietta Memorial Hospital /ID# 215929, Marietta, Ohio, United States|STAT Research, Inc. /ID# 215264, Springboro, Ohio, United States|Health Research of Oklahoma /ID# 215117, Oklahoma City, Oklahoma, United States|Oregon Health and Science University /ID# 216446, Portland, Oregon, United States|Altoona Ctr Clinical Res /ID# 214770, Duncansville, Pennsylvania, United States|Tekton Research, Inc. /ID# 214923, Austin, Texas, United States|Trinity Universal Res Assoc /ID# 214948, Carrollton, Texas, United States|Arth and Osteo Clin Brazo Valley /ID# 215805, College Station, Texas, United States|JPS Health Network /ID# 215962, Fort Worth, Texas, United States|Biopharma Informatic Research /ID# 215907, Houston, Texas, United States|Memorial Rheumatology /ID# 216311, Houston, Texas, United States|Biopharma Informatic, LLC /ID# 215885, Houston, Texas, United States|West Texas Clinical Research /ID# 215928, Lubbock, Texas, United States|Trinity Universal Research Association /ID# 215189, Plano, Texas, United States|Rheumatology and Pulmonary cli /ID# 214946, Beckley, West Virginia, United States|West Virginia Research Inst /ID# 214921, South Charleston, West Virginia, United States|Centro Medico Privado/Reuma /ID# 214559, San Miguel de Tucuman, Ciuadad Autonoma De Buenos Aires, Argentina|Instituto CAICI SRL /ID# 215242, Rosario, Santa Fe, Argentina|Organizacion Medica de Investigacion (OMI) /ID# 214557, Buenos Aires, Argentina|Hospital Cordoba /ID# 215846, Cordoba, Argentina|Inst. Rheumatologic Strusberg /ID# 215239, Cordoba, Argentina|Cimer /Id# 215240, San Miguel de Tucuman, Argentina|Centro de Enfermedades del Hígado y Aparato Digestivo /ID# 214556, Santa Fe, Argentina|Emeritus Research Sydney /ID# 215507, Kogarah, New South Wales, Australia|BJC Health /ID# 215510, Paramatta, New South Wales, Australia|Emeritus Research /ID# 215506, Camberwell, Victoria, Australia|Monash Health /ID# 215509, Clayton, Victoria, Australia|Barwon Rheumatology /ID# 215508, Geelong, Victoria, Australia|UZ Gent /ID# 215004, Gent, Oost-Vlaanderen, Belgium|ReumaClinic Genk /ID# 215005, Genk, Belgium|UZ Leuven /ID# 215006, Leuven, Belgium|CMiP - Centro Mineiro de Pesquisa Ltda - ME /ID# 215277, Juiz de Fora, Minas Gerais, Brazil|EDUMED Educacao em Saude S/S L /ID# 215111, Curitiba, Parana, Brazil|LMK Sevicos Medicos S/S /ID# 215112, Porto Alegre, Rio Grande Do Sul, Brazil|Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto /ID# 215176, Sao Jose Do Rio Preto, Sao Paulo, Brazil|CPCLIN - Centro de Pesquisas Clínicas /ID# 215175, Sao Paulo, Brazil|MHAT Kaspela /ID# 214803, Plovdiv, Bulgaria|MHAT-Plovdiv AD /ID# 214815, Plovdiv, Bulgaria|Unimed Medical Center /ID# 214816, Plovdiv, Bulgaria|Medical Center - Teodora EOOD /ID# 214813, Ruse, Bulgaria|Excelsior Medical Center /ID# 214805, Sofia, Bulgaria|Diag Consult Ctr 17 Sofia EOOD /ID# 214808, Sofia, Bulgaria|UMHAT Sv. Ivan Rilski /ID# 214804, Sofia, Bulgaria|UMHAT Sv. Ivan Rilski /ID# 214806, Sofia, Bulgaria|University of Alberta - Division of Rheumatology /ID# 216360, Edmonton, Alberta, Canada|Percuro Clinical Research, Ltd /ID# 215302, Victoria, British Columbia, Canada|Toronto Western Hospital /ID# 215041, Toronto, Ontario, Canada|Applied Medical Informatics Research Inc. (AMIR) /ID# 215303, Montréal, Quebec, Canada|Ctr. de Recherche Musculo-Sque /ID# 215096, Trois-rivières, Quebec, Canada|Centre de recherche du CHUQ /ID# 215038, Quebec, Canada|1st Aff Hosp of Bengbu Med Col /ID# 216609, Bengbu, Anhui, China|Anhui Provincial Hospital /ID# 216631, Hefei, Anhui, China|Guangdong Provincial People's Hospital /ID# 216645, Guangzhou, Guangdong, China|The First Affiliated Hospital of Shantou University Medical College /ID# 217883, Shantou, Guangdong, China|Zhuzhou Central Hospital /ID# 216644, Zhuzhou, Hunan, China|The First Affiliated Hospital of Baotou Medical College, Inner Monggolia Univers /ID# 216612, Baotou, Inner Mongolia, China|Peking Union Med College Hosp /ID# 216545, Beijing, China|First Affiliated Hospital of Kunming Medical University /ID# 217945, Kunming, China|The First Affiliated Hospital of Soochow University /ID# 216607, Soochow, China|People's Hospital of Xinjiang /ID# 216630, Urumqi, China|First Affiliated Hospital of Xi'an Jiaotong University /ID# 216614, Xi'an, China|Revmatologicky ustav Praha /ID# 215154, Prague 2, Praha 2, Czechia|Revmatologicka ambulance /ID# 215652, Prague 4, Praha 4, Czechia|Thomayerova nemocnice /ID# 215118, Prague, Praha 4, Czechia|Fakultni Nemocnice v Motole /ID# 215160, Prague 5, Praha 5, Czechia|PV MEDICAL Services s.r.o. /ID# 215119, Zlín 1, Zlin, Czechia|REVMACLINIC s.r.o. /ID# 215153, Brno, Czechia|Revmacentrum MUDr. Mostera /ID# 215161, Brno, Czechia|Revmatologie, s.r.o. /ID# 215309, Brno, Czechia|CCR Ostrava s.r.o. /ID# 215226, Ostrava 2, Czechia|ARTHROHELP, s.r.o. /ID# 215224, Pardubice, Czechia|FN Plzen /ID# 215162, Plzen, Czechia|Medical Plus, s.r.o. /ID# 215324, Uherské Hradište, Czechia|CHU Toulouse /ID# 214780, Toulouse CEDEX 3, Occitanie, France|CHU Bordeaux-Hopital Pellegrin /ID# 214784, Bordeaux, France|Hopital Ambroise Pare /ID# 214783, Boulogne Billancourt, France|Groupe Hospitalier Cochin /ID# 214782, Paris, France|Universitaetsklinikum Erlangen /ID# 214281, Erlangen, Bayern, Germany|Rheumatologische Schwerpunktpraxis Brandt-Juergens /ID# 214282, Berlin, Germany|Charite-Univ. Berlin, Benjamin-Franklin /ID# 214211, Berlin, Germany|Rheuma Research Lausitz, Dr. Mario Sutowicz /ID# 214218, Cottbus, Germany|Universitaetsklinikum Dresden /ID# 214207, Dresden, Germany|Praxisgemeinschaft Rheumatolog /ID# 214212, Erlangen, Germany|Hamburger Rheuma Forschungszentrum II im MVZ Rheumatologie und Autoimmunmedizin /ID# 214208, Hamburg, Germany|Med Hochschule Hanover /ID# 214209, Hannover, Germany|MVZ Planegg /ID# 214261, Planegg, Germany|Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókórház /ID# 215180, Nyíregyháza, Szabolcs-Szatmar-Bereg, Hungary|Rehavita Kft /ID# 215188, Zalaegerszeg, Zala, Hungary|Betegapolo Irgalmas Rend - Budai Irgalmasrendi Korhaz /ID# 215183, Budapest, Hungary|Debreceni Egyetem Klinikai Központ /ID# 215187, Debrecen, Hungary|Bekes Megyei Pandy Kalman Korhaz /ID# 215186, Gyula, Hungary|Hevizgyogyfurdo es Szent Andra /ID# 215184, Heviz, Hungary|Pest Megyei Flor Ferenc Korhaz /ID# 214501, Kistarcsa, Hungary|University of Szeged /ID# 220902, Szeged, Hungary|C-MED/CMED Rehabilitációsközpont /ID# 215181, Szekesfehervar, Hungary|Vital Medical Center Orvosi-es Fogorvosi Kozpont /ID# 215182, Veszprem, Hungary|Tel Aviv Sourasky Medical Center /ID# 216956, Tel Aviv-Yafo, Tel-Aviv, Israel|Bnai Zion Medical Center /ID# 215856, Haifa, Israel|Meir Medical Center /ID# 217255, Kfar Saba, Israel|Sheba Medical Center /ID# 215854, Ramat Gan, Israel|A.O.U. Consorziale Policlinico di Bari /ID# 215072, Bari, Italy|Università Vita-Salute San Raffaele /ID# 215071, Milan, Italy|Azienda Ospedaliera Regionale San Carlo /ID# 215067, Potenza, Italy|A.O. Ordine Mauriziano /ID# 215073, Turin, Italy|ASST Sette Laghi /ID# 215069, Varese, Italy|Daido Clinic /ID# 214735, Nagoya-shi, Aichi, Japan|Matsuyama Red Cross Hospital /ID# 216021, Matsuyama-shi, Ehime, Japan|National Hospital Organization Asahikawa Medical Center /ID# 214930, Asahikawa-shi, Hokkaido, Japan|Hokkaido University Hospital /ID# 215221, Sapporo-shi, Hokkaido, Japan|Kobe University Hospital /ID# 214598, Kobe-shi, Hyogo, Japan|Hyogo College of Medicine College Hospital /Id# 215638, Nishinomiya-shi, Hyogo, Japan|Kuwana city medical center /ID# 215196, Kuwana City, Mie, Japan|Nagasaki University Hospital /ID# 215947, Nagasaki-shi, Nagasaki, Japan|Sasebo Chuo Hospital /ID# 214703, Sasebo-city, Nagasaki, Japan|Japanese Red Cross Okayama Hospital /ID# 214732, Okayama-shi, Okayama, Japan|National Hospital Organization Osaka Minami Medical Center /ID# 214205, Kawachinagano-shi, Osaka, Japan|Juntendo University Hospital /ID# 214929, Bunkyo-ku, Tokyo, Japan|St.Luke's International Hospital /ID# 215414, Chuo-ku, Tokyo, Japan|Kita-harima Medical Center /ID# 216069, ONO, Japan|Osaka City General Hospital /ID# 215640, Osaka, Japan|Okinawa Prefectural Chubu Hospital /ID# 215575, Uruma-shi, Japan|Ajou University Hospital /ID# 214533, Suwon-si, Gyeonggido, Korea, Republic of|Gachon University Gil Medical Center /ID# 214534, Incheon, Incheon Gwang Yeogsi, Korea, Republic of|Hanyang University Seoul Hospi /ID# 214297, Seongdong-gu, Seoul Teugbyeolsi, Korea, Republic of|Cath Univ Seoul St Mary's Hosp /ID# 214295, Seoul, Seoul Teugbyeolsi, Korea, Republic of|Seoul National University Hospital /ID# 214532, Seoul, Korea, Republic of|Kyung Hee University Hospital at Gangdong /ID# 214296, Seoul, Korea, Republic of|Asan Medical Center /ID# 214294, Seoul, Korea, Republic of|CINTRE, Centro de Investigación y Tratamiento Reumatológico SC /ID# 215217, Mexico City, Ciudad De Mexico, Mexico|Centro Integral en Reumatologia S.A de C.V /ID# 215218, Guadalajara, Jalisco, Mexico|Clinica de Investigacion en Reumatologia y Obesidad S.C. /ID# 215257, Guadalajara, Jalisco, Mexico|Centro de Estudios de Investigación Básica y Clínica, S.C. /ID# 215258, Guadalajara, Jalisco, Mexico|Centro de investigación de Tratamientos Innovadores de Sinaloa, S.C. /ID# 215256, Culiacán Rosales, Sinaloa, Mexico|Waikato Hospital /ID# 215503, Hamilton, Waikato, New Zealand|Middlemore Clinical Trials /ID# 215502, Auckland, New Zealand|WroMedica I. Bielicka, A. Strzalkowska s.c. /ID# 215093, Wrocław, Dolnoslaskie, Poland|Nasz Lekarz Przychodnie Medyczne /ID# 214352, Torun, Kujawsko-pomorskie, Poland|Osteo-Medic S.C. /ID# 214351, Białystok, Podlaskie, Poland|ETYKA-Osrodek Badan Klinicznyc /ID# 215572, Olsztyn, Warminsko-mazurskie, Poland|Reumed Sp. z o.o. Filia nr 1 /ID# 214353, Lublin, Poland|AI Centrum Medyczne Sp. z o.o. /ID# 214354, Poznań, Poland|Immanuel Kant Baltic Federal University /ID# 218259, Kaliningrad, Kaliningradskaya Oblast, Russian Federation|NW State Medical Univ na Mechn /ID# 214454, St. Petersburg, Leningradskaya Oblast, Russian Federation|Family Outpatient clinic#4 LLC /ID# 214455, Korolev, Moskva, Russian Federation|RIR named after V.A.Nasonova /ID# 214459, Moscow, Moskva, Russian Federation|LLC Medical Center /ID# 214410, Novosibirsk, Novosibirskaya Oblast, Russian Federation|LLC. Family Clinic /ID# 214737, Yekaterinburg, Sverdlovskaya Oblast, Russian Federation|Central City Hospital No.7 /ID# 214741, Yekaterinburg, Sverdlovskaya Oblast, Russian Federation|Alliance Biomedical Ural Group /ID# 214457, Izhevsk, Udmurtskaya Respublika, Russian Federation|Chelyabinsk Regional Clinical Hospital /ID# 214463, Chelyabinsk, Russian Federation|Kazan State University /ID# 214421, Kazan, Russian Federation|Llc Olla-Med /Id# 214460, Moscow, Russian Federation|City Clinical Hospital #15 /ID# 214486, Moscow, Russian Federation|Moscow RRCI M.F. Vladimirski /ID# 215887, Moscow, Russian Federation|Omsk Clinical Regional Hospita /ID# 214464, Omsk, Russian Federation|Orenburg State Medical Academy /ID# 214408, Orenburg, Russian Federation|LLC Novaya Clinica /ID# 214420, Pyatigorsk, Russian Federation|Ryazan State Medical Universit /ID# 214418, Ryazan, Russian Federation|Clinical Rheumatologic Hospital No 25 /ID# 214488, Sankt-Peterburg, Russian Federation|Private Healthcare Institution Clinical Hospital RZD - Medicine Saratov /ID# 214465, Saratov, Russian Federation|Ulyanovsk Regional Clinical Ho /ID# 214458, Ulyanovsk, Russian Federation|UNB, Nemocnica Stare Mesto /ID# 214675, Bratislava, Slovakia|Reum.hapi s.r.o. /ID# 224268, Nove Mesto nad Vahom, Slovakia|Narodny ustav reumatickych chorob /ID# 214674, Piestany, Slovakia|MUDr. Zuzana Cizmarikova s.r.o. /ID# 215220, Poprad, Slovakia|ALBAMED s.r.o. /ID# 215248, Zvolen, Slovakia|Hospital Marina Baixa /ID# 215970, Villajoyosa, Alicante, Spain|Hospital Parc Tauli de Sabadell /ID# 214967, Sabadell, Barcelona, Spain|Hospital Unversitario Marques de Valdecilla /ID# 214965, Santander, Cantabria, Spain|Hospital Meixoeiro (CHUVI) /ID# 214969, Vigo, Pontevedra, Spain|Hospital Universitario Reina Sofia /ID# 214968, Cordoba, Spain|Hospital Universitario La Paz /ID# 216032, Madrid, Spain|Hospital Universitario y Politecnico La Fe /ID# 214966, Valencia, Spain|Kaohsiung Veterans General Hos /ID# 214332, Kaohsiung, Taichung, Taiwan|China Medical University Hosp /ID# 214019, Taichung City, Taichung, Taiwan|Far Eastern Memorial Hospital /ID# 215384, New Taipei City, Taiwan|Chung Shan Medical University /ID# 214018, Taichung City, Taiwan|Cathay General Hospital /ID# 214183, Taipei City, Taiwan|Hacettepe Universitesi Tip Fak /ID# 214898, Sihhiye, Ankara, Turkey|Ankara Univ Medical Faculty /ID# 214896, Ankara, Turkey|Istanbul Universitesi Cerrahpa /ID# 214895, Cerrahpasa, Turkey|Mugla Sitki Kocman University Medical Faculty /ID# 215358, Mugla, Turkey|Vinnytsia Regional Clinical Hospital n.a. M.I.Pyrogov /ID# 214147, Vinnytsia, Vinnytska Oblast, Ukraine|Scientific Research Institute of Invalid Rehabilitation /ID# 214148, Vinnytsia, Vinnytska Oblast, Ukraine|MNPE Chernihiv Regional Hospital /ID# 214145, Chernihiv, Ukraine|PNE City Multifunctional Hospital No.18 /ID# 214154, Kharkiv, Ukraine|SI L.T. Malaya Therapy National Institution of NAMS of Ukraine /ID# 214155, Kharkiv, Ukraine|Kharkiv Regional Council Regional Clinical Hospital /ID# 214158, Kharkiv, Ukraine|MNI Khmelnitskyi Regional Hospital /ID# 214153, Khmelnitskyi, Ukraine|MI Kryvyi Rih City Clinical Hospital No.2 /ID# 214152, Kryvyi Rih, Ukraine|Kyiv Railway Clinical Hosp No.2 /ID# 214779, Kyiv, Ukraine|Medical centre of CONSILIUM MEDICAL LLC /ID# 216234, Kyiv, Ukraine|LLC Revmocentr /ID# 214146, Kyiv, Ukraine|MNI KRC Kyiv Regional Clinical Hospital /ID# 214156, Kyiv, Ukraine|Odessa Regional Clinical Hosp /ID# 214159, Odesa, Ukraine|Poltava Reg Clin Hosp Sklifoso /ID# 214151, Poltava, Ukraine|Ternopil University Hospital /ID# 214705, Ternopil, Ukraine|Multifield Medical Centre of ONMU /ID# 214149, Оdesa, Ukraine|Norfolk and Norwich Univ Hosp /ID# 214865, Norwich, Norfolk, United Kingdom|Royal United Hospitals Bath /ID# 214864, Bath, United Kingdom|West Suffolk Hospital /ID# 215529, Bury St Edmunds, United Kingdom|Doncaster Royal Infirmary /ID# 214971, Doncaster, United Kingdom|Queen Alexandra Hospital /ID# 216624, Portsmouth, United Kingdom|Lancashire Care NHS Foundation /ID# 216226, Preston, United Kingdom|Haywood Hospital /Id# 214860, Stoke on Trent, United Kingdom|The Royal Wolverhampton NHS Tr /ID# 214876, Wolverhampton, United Kingdom",,,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0,0.0,1.0,0.0,0.0,0.0,53.0,68.53528819893633,6.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.57,380.375,78.32,3.0,2.0,4.0,36.09,93.03,4.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0
Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,ANKYLOSING SPONDYLITIS,_MELOXICAM,NCT04480359,Phase 2|Phase 3,Recruiting,All,"18 Years to 70 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, China",6184220,5,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,13.0,22.47274071336161,1458.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.28,351.401,99.6,5.0,2.0,3.0,34.25,88.62,2.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,MYASTHENIA GRAVIS,_ALBUTEROL,NCT03914638,Phase 2|Phase 3,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","Department of Neurology, Aalborg University Hospital, Aalborg, Denmark|Neurology, Aarhus University Hospital, Aarhus, Denmark",5775321,B65D83/54,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,29.0,42.4813651204336,760.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.44,239.3107,72.72,4.0,4.0,1.0,26.86,67.87,5.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,UVEITIS,_BARICITINIB,NCT04088409,Phase 3,Recruiting,All,2 Years to 17 Years   (Child),Industry,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"Hospices Civils de Lyon - Hôpital Femme Mère Enfant, Bron, France|Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre, Le Kremlin Bicetre, France|Centre Hospitalier Universitaire de Nîmes - Hôpital Universitaire Carémeau, Nîmes, France|GH Necker - Enfants Malades, Paris Cedex 15, France|CHU Poitiers - Hopital Jean Bernard, Poitiers Cedex, France|Asklepios Klinik Sankt Augustin, Saint Augustin, Nordrhein-Westfalen, Germany|HELIOS Klinikum Berlin-Buch, Berlin, Germany|Charité Campus Virchow-Klinikum, Berlin, Germany|Hamburger Zentrum für Kinder und Jugendrheumatologie, Hamburg, Germany|Ospedale Pediatrico Gaslini - Istituto Giannina Gaslini, Genova, Liguria, Italy|Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Lombardia, Italy|Azienda Ospedaliero Universitaria Meyer, Firenze, Italy|Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain|Hospital Infantil Universitario Niño Jesús, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario La Fe de Valencia, Valencia, Spain|Cambridge Clinical Research Facility, Cambridge, Cambridgeshire, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|Royal Victoria Infirmary, Newcastle, N'castle-upon-tyne, United Kingdom|Sheffield Children's Hospital, Sheffield, South Yorkshire, United Kingdom|Bristol Royal Hospital for Children, Bristol, United Kingdom|Alder Hey Children's Hospital, Liverpool, United Kingdom|Great Ormond Street Hospital For Children NHS Foundation Trust, London, United Kingdom",8158616,C07D487/04,1.0,0.0,0.0,0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0,0.0,1.0,0.0,0.0,0.0,3.0,37.257438551099604,12.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.08,371.42,120.56,6.0,1.0,4.0,36.72,105.55,4.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,OSTEO ARTHRITIS OF THE KNEES,_DEXTROSE,NCT03400631,Not Applicable,Recruiting,All,"21 Years to 75 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","Gaston Topol, M.D.. Private Office, Rosario, Santa Fe, Argentina",3964974,C12Q1/54,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,10.0,33.380562229203804,1910.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-2.6,180.1559,110.38,6.0,5.0,1.0,16.43,35.92,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0
CNCC[C@H](Oc1cccc2ccccc12)c1cccs1,OSTEO ARTHRITIS OF THE KNEES,_DULOXETINE,NCT04224584,Phase 2,Recruiting,All,"40 Years to 75 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","Mech-Sense, Aalborg, Denmark",5023269.0,C07D333/20,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,51.0,14.4890038809831,220.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,4.72,297.415,21.26,2.0,1.0,3.0,33.15,87.73,6.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21,OSTEO ARTHRITIS OF THE KNEES,_DRONABINOL,NCT04298528,Phase 3,Recruiting,All,"21 Years to 75 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","Colorado Joint Replacement, Denver, Colorado, United States",6703418.0,3,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,17.0,141.17743690835502,1151.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,7.29,314.4617,29.46,2.0,1.0,3.0,38.96,96.73,4.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,POLYMYALGIA RHEUMATICA,_PREDNISOLONE,NCT03576794,Phase 3,Recruiting,All,"50 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","ZGT Almelo, Almelo, Netherlands|University Medical Center Groningen, Groningen, Netherlands",5178878,A61K9/0056,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,13.0,8.903673586726619,1053.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.66,360.444,94.83,5.0,3.0,4.0,38.69,98.49,2.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0
Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,POLYMYALGIA RHEUMATICA,_LEFLUNOMIDE,NCT03576794,Phase 3,Recruiting,All,"50 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","ZGT Almelo, Almelo, Netherlands|University Medical Center Groningen, Groningen, Netherlands",5504084,2,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,16.0,24.345469106141802,1785.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.52,270.2073,55.13,2.0,1.0,2.0,23.11,64.16,3.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0
CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE,_PRAVASTATIN,NCT04284657,Phase 2,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"Keck School of Medicine of University of Southern California, Los Angeles, California, United States",5622985.0,4,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,19.0,24.1154849175547,325.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.23,424.5277,124.29,6.0,4.0,2.0,46.56,113.6,11.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+],AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE,_SODIUM_CITRATE,NCT04284657,Phase 2,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"Keck School of Medicine of University of Southern California, Los Angeles, California, United States",,,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,15.0,32.7488,128.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,-0.55,258.068,140.62,7.0,1.0,0.0,14.23,68.14,5.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,OSTEO ARTHRITIS OF THE KNEES,_TRIAMCINOLONE_HEXACETONIDE,NCT04231318,Phase 3,Recruiting,All,"40 Years to 75 Years   (Adult, Older Adult)",Industry,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","Tucson Orthopaedic Institute, Tucson, Arizona, United States|Ascension Research LLC, Pinellas Park, Florida, United States",4279900,C07J71/0031,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,67.0,23.8197909608,351.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.1233,442.0703,112.1969,5.0,2.0,3.0,44.7137,115.5493,5.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0
CC(=O)N[C@@H]1C(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(=O)O)O[C@@H](OC2[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]2NC(C)=O)[C@H](O)[C@H]1O,LUMBAR SPINAL STENOSIS,_HYALURONIC_ACID,NCT02459392,Not Applicable,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Czech republic, Praha, Czechia",,,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,15.0,32.7488,128.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,-1.8,776.6486,399.71,23.0,14.0,4.0,70.56,155.1,12.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0
NCCc1c[nH]c2ccc(O)cc12,STROKE,_SEROTONIN,NCT02865642,Phase 2,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","Neurology Department Kantonsspital St. Gallen, St. Gallen, Saint Gallen, Switzerland|Support Center of Advanced Neuroimaging Institute for Diagnostic and Interventional Neuroradiology Inselspital, University Hospital Bern, Bern, Switzerland",3930948,C12N9/88,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,3.0,17.281669028111402,4461.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.56,176.2151,62.04,2.0,3.0,2.0,19.31,52.35,2.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,JUVENILE IDIOPATHIC ARTHRITIS,_METHOTREXATE,NCT04169828,Not Applicable,Recruiting,All,4 Years to 16 Years   (Child),Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"University of Calgary / Alberta Children's Hospital, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada|BC Children's Hospital, Vancouver, British Columbia, Canada|University of Manitoba/Children's hospital research institute, Winnipeg, Manitoba, Canada|Memorial University/Janeway Childrens Health and Rehabilitation Centre, St. John's, Newfoundland and Labrador, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster University/McMaster Children's Hospital, Hamilton, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|Hospital for Sick Children, Toronto, Ontario, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Université de Montréal, Montréal, Quebec, Canada|University of Sherbrooke, Sherbrooke, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada",6746429,A61M5/2425,1.0,0.0,0.0,0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0,1.0,0.0,0.0,0.0,0.0,15.0,39.9186841618924,2117.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.91,454.4393,210.54,12.0,5.0,3.0,44.54,119.21,9.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0
Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,JUVENILE IDIOPATHIC ARTHRITIS,_ONDANSETRON,NCT04169828,Not Applicable,Recruiting,All,4 Years to 16 Years   (Child),Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"University of Calgary / Alberta Children's Hospital, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada|BC Children's Hospital, Vancouver, British Columbia, Canada|University of Manitoba/Children's hospital research institute, Winnipeg, Manitoba, Canada|Memorial University/Janeway Childrens Health and Rehabilitation Centre, St. John's, Newfoundland and Labrador, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster University/McMaster Children's Hospital, Hamilton, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|Hospital for Sick Children, Toronto, Ontario, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Université de Montréal, Montréal, Quebec, Canada|University of Sherbrooke, Sherbrooke, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada",5344658,C07D403/06,1.0,0.0,0.0,0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0,1.0,0.0,0.0,0.0,0.0,10.0,19.5486560298979,384.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.56,293.363,39.82,2.0,0.0,4.0,33.16,86.78,2.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,CHRONIC SHOULDER PAIN,_DEXTROSE,NCT03000205,Not Applicable,Recruiting,All,"20 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","Shuang Ho Hospital, New taipei city, Zhonghe Dist, Taiwan|Shuang Ho Hospital, New taipei city, Zhonghe Dist, Taiwan",3964974,C12Q1/54,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,10.0,33.380562229203804,1910.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-2.6,180.1559,110.38,6.0,5.0,1.0,16.43,35.92,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0
CC(C)NCC(O)COc1cccc2ccccc12,SHOULDER PAIN,_PROPRANOLOL,NCT02620579,Phase 2,Recruiting,All,18 Years to 64 Years   (Adult),Other|NIH,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","University of Florida Clinical and Translational Science Institute, Gainesville, Florida, United States",6500454,1,1.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0,0.0,0.0,0.0,1.0,0.0,25.0,14.8832624899895,1234.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.03,259.3434,41.49,3.0,2.0,2.0,29.98,76.83,6.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Clc1cccc(Cl)c1NC1=NCCN1,SCOLIOSIS,_CLONIDINE,NCT03537612,Phase 3,Recruiting,Female,"10 Years to 21 Years   (Child, Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Shriners Hospitals for Children - Canada, Montréal, Quebec, Canada",5869100,4,0.0,1.0,0.0,0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0,1.0,0.0,0.0,0.0,0.0,11.0,19.5486560298979,3720.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.55,230.09400000000002,36.42,3.0,2.0,2.0,21.7,59.09,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,SCOLIOSIS,_MORPHINE,NCT03537612,Phase 3,Recruiting,Female,"10 Years to 21 Years   (Child, Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Shriners Hospitals for Children - Canada, Montréal, Quebec, Canada",5378474.0,A61K9/5078,0.0,1.0,0.0,0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0,1.0,0.0,0.0,0.0,0.0,21.0,22.3413211770262,2179.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.99,285.3377,52.93,4.0,2.0,5.0,29.94,80.12,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0
CN(C)C(=N)NC(=N)N,RHEUMATOID ARTHRITIS|CARDIOVASCULAR DISEASES,_METFORMIN,NCT02246257,Not Applicable,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"Department of Rheumathology, Frederiksberg and Bispebjerg univeristy Hospital, Frederiksberg, Region Of Copenhagen, Denmark",6288095.0,4,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,10.0,80.757305078133,88.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,-1.8,129.1636,88.99,5.0,4.0,0.0,13.43,56.64,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,RHEUMATOID ARTHRITIS|CARDIOVASCULAR DISEASES,_SIMVASTATIN,NCT02246257,Not Applicable,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"Department of Rheumathology, Frederiksberg and Bispebjerg univeristy Hospital, Frederiksberg, Region Of Copenhagen, Denmark",RE42461,C07D205/08 ,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,8.0,200.973325940984,1639.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,4.51,418.5662,72.83,3.0,1.0,3.0,47.88,117.68,7.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,RHEUMATOID ARTHRITIS|CARDIOVASCULAR DISEASES,_LOSARTAN,NCT02246257,Not Applicable,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"Department of Rheumathology, Frederiksberg and Bispebjerg univeristy Hospital, Frederiksberg, Region Of Copenhagen, Denmark",5210079,4,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,31.0,15.0803917944927,357.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,4.5,422.911,92.51,5.0,2.0,4.0,44.86,131.85,8.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5,KNEE ARTHRITIS,_MORPHINE,NCT02967302,Phase 2|Phase 3,Recruiting,All,"18 Years to 80 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","Charité CBF Rheumatology, Berlin, Germany",5378474.0,A61K9/5078,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,21.0,22.3413211770262,2179.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.99,285.3377,52.93,4.0,2.0,5.0,29.94,80.12,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0
CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.O=S(=O)(O)O,KNEE ARTHRITIS,_MORPHINE_SULFATE,NCT02967302,Phase 2|Phase 3,Recruiting,All,"18 Years to 80 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","Charité CBF Rheumatology, Berlin, Germany",4083982,1,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,3.0,12.3205815314482,167.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.1233,442.0703,112.1969,5.0,2.0,3.0,44.7137,115.5493,5.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,HAND OSTEOARTHRITIS,_ESTROGEN,NCT04036929,Not Applicable,Recruiting,Female,"40 Years to 65 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","White Horse Medical Practice, Faringdon Medical Centre, Faringdon, Oxfordshire, United Kingdom|Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom|Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom",,,0.0,1.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0,1.0,0.0,0.0,0.0,0.0,15.0,32.7488,128.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,2.1233,442.0703,112.1969,5.0,2.0,3.0,44.7137,115.5493,5.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,JUVENILE IDIOPATHIC ARTHRITIS,_TOFACITINIB,NCT01500551,Phase 3,Recruiting,All,"2 Years to 18 Years   (Child, Adult)",Industry,Masking: None (Open Label)|Primary Purpose: Treatment,"Phoenix Children's Hospital- Inpatient Pharmacy, Phoenix, Arizona, United States|Phoenix Children's Hospital, Phoenix, Arizona, United States|Arkansas Children's Hospital- Attention: Jill Hernandez, Little Rock, Arkansas, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Loma Linda University Children'S Hospital, Loma Linda, California, United States|Loma Linda University Clinical Trials Center, Loma Linda, California, United States|Loma Linda University Eye Institute, Loma Linda, California, United States|Loma Linda University General Pediatric Clinic - Meridian, Loma Linda, California, United States|Pediatric Speciality Team Centers of LLU Children's Hospital (Rheumatology), Loma Linda, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Pediatric Speciality Team Centers of LLU Children's Hospital (Rheumatology), San Bernardino, California, United States|Rady Children's Hospital Center for Pediatric Clinical Research, San Diego, California, United States|Rady Children's Hospital Education and Office Building, San Diego, California, United States|Rady Children's Hospital Research Pharmacy, San Diego, California, United States|Rady Children's Hospital Rheumatology Clinic, San Diego, California, United States|Rady Children's Hospital San Diego, San Diego, California, United States|Connecticut Children's Medical Center Pharmacy, Hartford, Connecticut, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Children's National Medical Center, Washington, District of Columbia, United States|IDS Pharmacy, Washington, District of Columbia, United States|Nicklaus Children's Hospital, Miami, Florida, United States|Johns Hopkins All Children's Hospital, Saint Pertersburg, Florida, United States|All Children's Hospital Speciality Physicians, Saint Petersburg, Florida, United States|Children's Healthcare of Atlanta-Pediatric Research Center, Atlanta, Georgia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Children's Specialty Services, Atlanta, Georgia, United States|Augusta University Health Pharmacy, Augusta, Georgia, United States|Augusta University, Augusta, Georgia, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Lurie Children's Investigational Drug Pharmacy, Chicago, Illinois, United States|Lurie Rheumatology Offices, Chicago, Illinois, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|IU Health Investigational Drug Services, Indianapolis, Indiana, United States|Riley Hospital for Children at IU Health, Indianapolis, Indiana, United States|Tufts Medical Center - Floating Hospital for Children, Boston, Massachusetts, United States|Explorer Clinic, University of Minnesota Children's Hospital, Minneapolis, Minnesota, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|Pharmacy Department, Bronx, New York, United States|Cohen Children's Medical Center of New York, Lake Success, New York, United States|Cohen Children's Medical Center of New York, New Hyde Park, New York, United States|Columbia University Medical Center-Herbert Irving Pavillion, New York, New York, United States|Pediatric Research, Charlotte, North Carolina, United States|Levine Children's Specialty Center, Charlotte, North Carolina, United States|Atrium Health- Investigational Drug Services, Charlotte, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Legacy Emanuel Medical Center - Inpatient Pharmacy, Portland, Oregon, United States|Randall Children's Hospital at Legacy Emanuel, Portland, Oregon, United States|The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Dell Children's Medical Group, Dell Children's Medical Center, Austin, Texas, United States|Texas Children's Hospital- Clinical Care Center, Houston, Texas, United States|Texas Children's Hospital- Clinical Research Center, Houston, Texas, United States|Texas Children's Hospital- Investigational Pharmacy, Houston, Texas, United States|Texas Children's Hospital- Main Hospital, Houston, Texas, United States|Texas Children's Hospital/Baylor College of Medicine- Feigin Center, Houston, Texas, United States|Primary Children's Hospital, Salt Lake City, Utah, United States|Seattle Children's Hospital, Seattle, Washington, United States|Instituto CAICI SRL, Rosario, Santa FE, Argentina|Centro Medico Privado de Reumatologia, San Miguel de Tucuman, Tucuman, Argentina|Hospital Britanico de Buenos Aires, Caba, Argentina|The Children's Hospital at Westmead, Westmead, New South Wales, Australia|The Royal Children's Hospital, Parkville, Victoria, Australia|UZ Leuven - Gasthuisberg, Leuven, Belgium|SER - Serviços Especializados em Reumatologia, Salvador, Bahia, Brazil|CMIP - Centro Mineiro de Pesquisa Ltda, Juiz de Fora, Minas Gerais, Brazil|Hospital Pequeno Príncipe/, Curitiba, Parana, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, RIO Grande DO SUL, Brazil|Faculdade de Medicina da UNESP, Botucatu, SAO Paulo, Brazil|Hospital de Clinicas da UNICAMP-Laboratorio de Reumatologia-L06, Campinas, SAO Paulo, Brazil|Hospital de Clinicas da UNICAMP, Campinas, SAO Paulo, Brazil|Instituto de Puericultura e Pediatria Martagao Gesteira (IPPMG), Rio de Janeiro, Brazil|SPDM - Associacao Paulista para o Desenvolvimento da Medicina, Sao Paulo, Brazil|Instituto da Crianca do Hospital das Clinicas da FMUSP, Sao Paulo, Brazil|Alberta Children's Hospital, Calgary, Alberta, Canada|Teck Acute Care Centre, Vancouver, British Columbia, Canada|C & W Health Centre of BC, Vancouver, British Columbia, Canada|British Columbia Children's Hospital, Vancouver, British Columbia, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada|McGill University Health Center, Glen Site, Central Pharmacy, Montreal, Quebec, Canada|McGill University Health Center, Glen Site, Montreal, Quebec, Canada|Bioreuma, Concepcion, Chile|Children's Hospital of Chongqing Medical University, Chongqing, Chongqing, China|Children's Hospital Affiliated to Capital Institute of Pediatrics/Rheumatology Immunology, Beijing, China|Children's Hospital of Fudan University, Shanghai, China|PRI - Pediatric Rheumatology Research Institute GmbH, Bad Bramstedt, Germany|Klinikum Bremen-Mitte, Prof. Hess-Kinderklinik, Bremen, Germany|Hamburger Zentrum fur Kinder und Jugendrheumatologie, Hamburg, Germany|Asklepios Klinik Sankt Augustin GmbH, Sankt Augustin, Germany|Rambam Health Care, Haifa, Israel|Meir Medical Center, Kfar Saba, Israel|Chaim Sheba M.C Tel hashomer, Ramat Gan, Israel|Clínica de Investigacion en Reumatologia y Obesidad, S.C., Guadalajara, Jalisco, Mexico|Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"", Monterrey, Nuevo LEON, Mexico|Hospital Central ""Dr. Ignacio Morones Prieto"", San Luis Potosi, Mexico|Unidad de Investigaciones Reumatologicas A.C., San Luis Potosi, Mexico|Centro de Alta Especialidad en Reumatología e Investigación del Potosí, S.C., San Luis Potosí, Mexico|Wojewodzki Szpital Dzieciecy im. J. Brudzinskiego, Bydgoszcz, Poland|Wojewodzki Specjalistyczny Szpital Dzieciecy im. Sw. Ludwika w Krakowie, Krakow, Poland|Klinika Kardiologii i Reumatologii Dzieciecej, Lodz, Poland|Centrum Pediatrii im. Jana Pawla II w Sosnowcu Sp. z o.o., Sosnowiec, Poland|FSBEI HE BSMU MoH RF, Ufa, Republic OF Bashkortostan, Russian Federation|Clinic of FSBEI HE BSMU MoH RF, Ufa, Republic OF Bashkortostan, Russian Federation|FSBEI HE ""Kazan SMU"" MoH RF, Kazan, Russian Federation|SAHI CRCH MoH TR, Kazan, Russian Federation|Federal State Budgetary Scientific Institution, Moscow, Russian Federation|FSAEI HE I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenovskiy University), Moscow, Russian Federation|FSAEI HE I.M. Sechenov First MSMU of Minzdrav of Russia (Sechenovskiy University),, Moscow, Russian Federation|FSAI ""NMRCCH"" of MOH Russia, Moscow, Russian Federation|FSBEI HE ""St. Petersburg State Pediatric Medical University"" of the Ministry of Healthcare, Saint-Petersburg, Russian Federation|FSBEI HE Saratov SMU n.a. V.I.Razumovskiy MoH RF, Saratov, Russian Federation|FSBEI HE Saratov SMU n.a. V.I.Razumovskiy MoH RF, Saratov, Russian Federation|State Budgetary Healthcare Institution of Samara Region ""Tolyatti City Clinical Hospital #5"", Tolyatti, Russian Federation|State Budgetary Healthcare Institution of Sverdlovsk Region, Yekaterinburg, Russian Federation|Narodny ustav reumatickych chorob, Piestany, Slovakia|Panorama Medical Centre, Panorama, Cape Town, South Africa|Emmed Research, Pretoria, Gauteng, South Africa|Enhancing Care Foundation, Durban, Kwa-zulu Natal, South Africa|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario y Politecnico La Fe, Valencia, Spain|Hacettepe University Ihsan Dogramaci Children Hospital, Ankara, Turkey|Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey|Istanbul Medeniyet University Medical Faculty, Istanbul, Turkey|Umraniye Training and Research Hospital, Istanbul, Turkey|Erciyes University Medical Faculty, Kayseri, Turkey|Communal Institution ""Dnipropetrovsk Specialized Clinical Medical Center of Mother and Child n.a., Dnipro, Ukraine|Municipal non-Profit Enterprise, Ivano-Frankivsk, Ukraine|Communal Institution of Lviv Regional Council, Lviv, Ukraine|Vinnytsia Regional Children's Clinical Hospital, Vinnitsya, Ukraine|Birmingham Woman's and Children's NHS Foundation Trust, Birmingham, WEST Midlands, United Kingdom",7301023,C07D487/04,1.0,0.0,0.0,0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0,0.0,1.0,0.0,0.0,0.0,1.0,66.1697365448982,52.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.58,312.3696,88.91,5.0,1.0,3.0,32.65,87.8,3.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,AXIAL SPONDYLOARTHRITIS,_TOFACITINIB,NCT03738956,Phase 2|Phase 3,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"Bangabandhu sheikh mujib medical university, Dhaka, Bangladesh",7301023,C07D487/04,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,1.0,66.1697365448982,52.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.58,312.3696,88.91,5.0,1.0,3.0,32.65,87.8,3.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,JUVENILE IDIOPATHIC ARTHRITIS,_BARICITINIB,NCT03773978,Phase 3,Recruiting,All,2 Years to 17 Years   (Child),Industry,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","Instituto CAICI SRL, Rosario, Santa Fe, Argentina|Centro Medico Privado de Reumatologia, SAN M. DE Tucuman, Tucuman, Argentina|Hospital General de Niños Dr. Pedro de Elizalde, Buenos Aires, Argentina|The Sydney Children's Hospitals Network, Westmead, New South Wales, Australia|Royal Childrens Hospital Melbourne, Parkville, Victoria, Australia|Perth Children's Hospital, Nedlands, Western Australia, Australia|LKH Bregenz, Bregenz, Vorarlberg, Austria|AKH, Wien, Austria|UCL- Saint Luc, Brussels, Brussels-Capital, Belgium|UZ Gent-Reuma, Gent, East Flanders, Belgium|Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium|CMIP - Centro Mineiro de Pesquisa, Juiz de Fora, Minas Gerais, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil|Faculdade de Medicina de Botucatu, Botucatu, Sao Paulo, Brazil|Faculdade de Ciências Médicas - UNICAMP, Campinas, Sao Paulo, Brazil|Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, Brazil|Children's hospital of Nanjing, Nanjing, Jiangsu, China|Children's Hospital of Chongqing Medical University, Chongqing, Tianjin City, China|Capitol Institute of Pediatrics Children'S Hospital, Beijing, China|Beijing Children's hospital, Capital Medical University, Beijing, China|Children's Hospital of Soochow University, Suzhou, China|Centrum detske revmatologie VFN, Klinika detskeho a dorostoveho lekarstvi 1.LFUK a VFN v Praze, Prague, Czechia|Fakultni Nemocnice v Motole, Praha 5, Czechia|Aarhus Universitetshospital, Skejby, Aarhus, Denmark|Paediatric rheumatology Unit, København Ø, Denmark|Hospices Civils de Lyon - Hôpital Femme Mère Enfant, Bron, France|Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre, Le Kremlin Bicetre, France|Centre Hospitalier Universitaire de Nîmes - Hôpital Universitaire Carémeau, Nîmes, France|GH Necker - Enfants Malades, Paris Cedex 15, France|CHU la Miletrie, Poitiers, France|Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany|Universitätsklinikum Tübingen, Tübingen, Baden-Württemberg, Germany|Asklepios Klinik Sankt Augustin, Saint Augustin, Nordrhein-Westfalen, Germany|HELIOS Klinikum Berlin-Buch, Berlin, Germany|Charité Campus Virchow-Klinikum, Berlin, Germany|Schön Klinik Hamburg Eilbek, Hamburg, Germany|Sri Ramachandra MedicaL College & Research Institute, Porur, Chennai, India|Sir Ganga Ram Hospital, New Delhi, Delhi, India|Christian Medical College Vellore, Vellore, Tamil Nadu, India|Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India|Rambam Medical Center, Haifa, Israel|Meir Medical Center, Kfar Saba, Israel|Schneider Children's Medical Center, Petah Tiqva, Israel|Sheba Medical Center, Ramat Gan, Israel|A.O.U. Ospedali Riuniti- Presidio ""G. Salesi"" -Reumatologia Pediatrica, Ancona, Italy|ASST Spedali Civili - Università degli Studi, Brescia, Italy|Ospedale SS. Annunziata, Chieti, Italy|Azienda Ospedaliero Universitaria Meyer, Firenze, Italy|Ospedale Pediatrico Gaslini - Istituto Giannina Gaslini, Genova, Italy|Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milano, Italy|Azienda Ospedaliera Universitaria Federico II, Napoli, Italy|Azienda Ospedaliera - Universitaria Pisana, Pisa, Italy|Ospedale Infantile Burlo Garofolo, Trieste, Italy|Kanazawa University Hospital, Kanazawa, Ishikawa, Japan|Kanagawa Children's Medical Center, Yokohama, Kanagawa, Japan|Yokohama City University Hospital, Yokohama, Kanagawa, Japan|Miyagi Children's Hospital, Sendai, Miyagi, Japan|Osaka Medical College Hospital, Takatsuki, Osaka, Japan|Saitama Children's Medical Center, Saitama-shi, Saitama, Japan|Tokyo Medical And Dental University Medical Hospital, Bunkyō, Tokyo, Japan|St. Lukes International Hospital, Chuo-Ku, Tokyo, Japan|Tokyo Women's Medical University Hospital, Shinjuku-ku, Tokyo, Japan|Kagoshima University Hospital, Kagoshima, Japan|Niigata University Medical & Dental Hospital, Niigata, Japan|Clinstile, S.A. de C.V., Cuauhtemoc, Federal District, Mexico|CREA de Guadalajara, S.C., Guadalajara, Jalisco, Mexico|Hospital Univ. ""Dr. José Eleuterio González"", Monterrey, Nuevo León, Mexico|Investigacion y Biomedicina de Chihuahua, Chihuahua, Mexico|Instituto de Investigaciones Aplicadas a la Neurociencia A.C, Durango, Mexico|Wojewódzki Specjalistyczny Szpital Dziecięcy im. św. Ludwika w Krakowie, Krakow, Poland|CSK, Uniwersyteckie Centrum Pediatrii im.M.Konopnickiej,Klinika Kardiologii i Reumatologii Dzieciecej, Lodz, Poland|Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji, Warszawa, Poland|V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian Federation|Morozovsky Children's City Clinical Hospital, Moscow, Russian Federation|First Moscow State Medical University n.a. Sechenov, Moscow, Russian Federation|Scientific Center of Children's Health, Moscow, Russian Federation|Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation|Hospital Sant Joan de Deu, Barcelona, Cataluna, Spain|Complexo Hospitalario Universitario A Coruña, CHUAC, La Coruña, Spain|Hospital Infantil Universitario Niño Jesús, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario La Fe de Valencia, Valencia, Spain|Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey|Dokuz Eylul University Hospital, Izmir, Turkey|University College Hospital - London, London, Greater London, United Kingdom|Great Ormond Street Hospital For Children NHS Foundation Trust, Bloomsbury, London, United Kingdom|Sheffield Children's Hospital, Sheffield, South Yorkshire, United Kingdom|Bristol Royal Hospital for Children, Bristol, United Kingdom|Alder Hey Children's Hospital, Liverpool, United Kingdom",8158616,C07D487/04,1.0,0.0,0.0,0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0,0.0,1.0,0.0,0.0,0.0,3.0,37.257438551099604,12.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.08,371.42,120.56,6.0,1.0,4.0,36.72,105.55,4.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0
N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,KNEE OSTEOARTHRITIS,_GLUCOSAMINE,NCT04470336,Not Applicable,Recruiting,All,"40 Years to 65 Years   (Adult, Older Adult)",Industry,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","Dr. Randive's Knee & Spine Clinic, Mumbai, Mahararashtra, India|Kurla Nursing Home, Mumbai, Maharashtra, India|Rainbow Multispeciality hospital and trauma center, Navi Mumbai, Maharashtra, India",4120954,C07H13/08,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,21.0,18.431589971046602,17.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-2.7,179.1711,116.17,6.0,5.0,1.0,16.87,37.58,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0
Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,MUSCULOSKELETAL PAIN,_ETORICOXIB,NCT04565600,Phase 2,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention,"Guangdong General Hospital, Guangzhou, Guangdong, China",5861419,C07D213/65,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,19.0,18.300170434711106,383.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,3.7,358.842,59.92,4.0,0.0,3.0,36.42,95.04,3.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0
O=[O+][O-],KNEE OSTEOARTHRITIS,_OZONE,NCT04426721,Phase 3,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","Humanitas Clinical and Research Hospital, Rozzano, Milano, Italy",,,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,15.0,32.7488,128.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,-0.21,47.997,74.27,3.0,0.0,0.0,2.31,4.24,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,JUVENILE IDIOPATHIC ARTHRITIS,_UPADACITINIB,NCT03725007,Phase 1,Recruiting,All,2 Years to 17 Years   (Child),Industry,Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment,"Ann & Robert H. Lurie Children's Hospital of Chicago /ID# 211162, Chicago, Illinois, United States|University of Louisville /ID# 202896, Louisville, Kentucky, United States|Boston Childrens Hospital /ID# 202993, Boston, Massachusetts, United States|Cincinnati Childrens Hosp Med /ID# 209697, Cincinnati, Ohio, United States|Randall Children's Hospital /ID# 213609, Portland, Oregon, United States|Children's Hospital of Philadelphia /ID# 209617, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC /ID# 202994, Pittsburgh, Pennsylvania, United States|Seattle Children's Hospital /ID# 203003, Seattle, Washington, United States|PRI - Pediatric Rheumatology Research Institute /ID# 205954, Bad Bramstedt, Germany|Helios Klinikum Berlin Buch /ID# 206859, Berlin, Germany|Kinder- & Jugendrheumatologie /ID# 206571, Hamburg, Germany|Asklepios Klinik St. Augustin /ID# 203264, Sankt Augustin, Germany|Semmelweis Egyetem II. Számú Gyermekgyógyászati Klinika /ID# 208970, Budapest VIII, Pest, Hungary|IRCCS Ospedale Pediatrico Bambino Gesù /ID# 203835, Rome, Lazio, Italy|Azienda Ospedaliero Universitaria Meyer /ID# 215576, Florence, Italy|IRCCS Istituto G. Gaslini /ID# 203648, Genoa, Italy|Centro de Reumatologia Pediatrico de Puerto Rico /Id# 204406, Bayamon, Puerto Rico|GCM Medical Group PSC - Hato Rey /ID# 211702, San Juan, Puerto Rico|Mindful Medical Research /ID# 204488, San Juan, Puerto Rico|Hospital Sant Joan de Deu /ID# 203915, Esplugues de Llobregat, Spain|Hospital Infantil Universitario Nino Jesus /ID# 206466, Madrid, Spain|Hospital Univ Ramon y Cajal /ID# 203917, Madrid, Spain|Hospital Universitario La Paz /ID# 203927, Madrid, Spain|Hospital Universitario La Fe /ID# 203914, Valencia, Spain",,,1.0,0.0,0.0,0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,53.0,68.53528819893633,6.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.57,380.375,78.32,3.0,2.0,4.0,36.09,93.03,4.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0
CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O,DIABETIC FOOT ULCER,_TREPROSTINIL,NCT03654989,Phase 1|Phase 2,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","CHU Grenoble Alpes, Grenoble, France",5153222.0,3,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,2.0,15.770344360253803,26.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.53,390.5131,86.99,5.0,3.0,3.0,45.74,108.0,10.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,PAIN MANAGEMENT,_METHYLPREDNISOLONE,NCT03564106,Phase 2|Phase 3,Recruiting,All,"18 Years to 65 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","Assiut governorate, Assiut, Egypt",3962414,A61F9/0017,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,9.0,19.450091377646306,446.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.06,374.4706,94.83,5.0,3.0,4.0,40.77,103.04,2.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0
CN(CC(=O)O)C(=N)N,KNEE OSTEOARTHRITIS,_CREATINE,NCT04423432,Not Applicable,Recruiting,All,"40 Years to 70 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","Foundation University Institute of Rehabilitation Sciences, Islamabad, Federal, Pakistan",,,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,15.0,32.7488,128.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,-1.6,131.1332,90.41,5.0,3.0,0.0,12.17,42.01,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0
CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,LATERAL EPICONDYLITIS,_PIROXICAM,NCT04201249,Phase 2|Phase 3,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","Hospital de Santa Maria, Lisboa, Portugal",4289879,C07D275/06,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,4.0,11.5320643134355,1236.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.2,331.346,99.6,5.0,2.0,3.0,32.27,87.04,2.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,1.0
CCN(CC)CC(=O)Nc1c(C)cccc1C,LATERAL EPICONDYLITIS,_LIDOCAINE,NCT04201249,Phase 2|Phase 3,Recruiting,All,"18 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","Hospital de Santa Maria, Lisboa, Portugal",5234957.0,1,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,23.0,19.5815109139818,1859.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.81,234.3373,32.34,2.0,1.0,1.0,27.77,73.93,5.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0
CC1CCC(C(C)C)C(O)C1,ACUTE PAIN,_MENTHOL,NCT04484428,Phase 2,Recruiting,All,18 Years to 35 Years   (Adult),Industry,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","Lotus Clinical Research, LLC, Pasadena, California, United States",3940875,A01M1/02,1.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,14.0,18.7601388118852,7457.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.1233,442.0703,112.1969,5.0,2.0,3.0,44.7137,115.5493,5.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0
Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,KNEE OSTEOARTHRITIS,_RESVERATROL,NCT02905799,Phase 3,Recruiting,All,"40 Years and older   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Supportive Care","Rehabilitation department , CHU Clermont-Ferrand, Cebazat, France|Rheumatology Department, Saint Antoine Hospital, Paris, France|Rehabilitation Department, Cochin Hospital, Paris, France",5747536,0,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,20.0,19.05583276864,5538.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.57,228.2433,60.69,3.0,3.0,2.0,24.55,67.46,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,"OSTEOARTHRITIS, HIP",_ZOLEDRONIC_ACID,NCT04303026,Phase 3,Recruiting,All,"50 Years to 80 Years   (Adult, Older Adult)",Other,"Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","Martina Hansens Hospital, Sandvika, Norway",4939130.0,C07F9/65031,1.0,0.0,0.0,0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0,1.0,0.0,0.0,0.0,0.0,5.0,16.1317480851762,6.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.93,272.0896,153.11,8.0,5.0,1.0,20.1,52.16,4.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0
